Piper Sandler Upgrades Solid Biosciences (SLDB) to Overweight, 'Still See Significant Upside Potential Despite Recent Move'
Tweet Send to a Friend
(Updated - March 14, 2024 4:31 AM EDT)
Piper Sandler analyst Christopher Raymond upgraded Solid Biosciences (NASDAQ: SLDB) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Christopher Raymond upgraded Solid Biosciences (NASDAQ: SLDB) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
